Clinical Trials Browser

NIH × Carcinoma, Ovarian Epithelial × Sorafenib × Clear all

NCT00096395 2013-06-13

Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial